Showing results (1-10 of 134) with videos related to
Sort By:
Pageof 14
Current Opinion in Immunology|April 23, 2026
CRAC channels as targets for immunotherapyKenneth Stauderman, Sudarshan Hebbar, Stefan FeskePancreas|May 3, 2021
Auxora for the Treatment of Patients With Acute Pancreatitis and Accompanying Systemic Inflammatory Response Syndrome: Clinical Development of a Calcium Release-Activated Calcium Channel InhibitorCharles Bruen, Joseph Miller, John Wilburn, et al.Critical Care (London, England)|August 16, 2020
Auxora versus standard of care for the treatment of severe or critical COVID-19 pneumonia: results from a randomized controlled trialJoseph Miller, Charles Bruen, Michael Schnaus, et al.Critical Care (London, England)|April 9, 2022
Auxora vs. placebo for the treatment of patients with severe COVID-19 pneumonia: a randomized-controlled clinical trialCharles Bruen, Mukhtar Al-Saadi, Edward A Michelson, et al.Cell Calcium|April 23, 2019
CRAC channels and disease - From human CRAC channelopathies and animal models to novel drugsStefan FeskeNature Reviews. Immunology|August 19, 2007
Calcium signalling in lymphocyte activation and diseaseStefan FeskeImmunological Reviews|September 17, 2009
ORAI1 and STIM1 deficiency in human and mice: roles of store-operated Ca2+ entry in the immune system and beyondStefan FeskeAnnals of the New York Academy of Sciences|December 2, 2011
Immunodeficiency due to defects in store-operated calcium entryStefan FeskeF1000Research|March 24, 2018
NFAT control of immune function: New Frontiers for an Abiding TrooperMartin Vaeth, Stefan FeskePageof 14